On August 13, 2024, Director Anthony Semedo of Artivion Inc (AORT, Financial) executed a sale of 9,709 shares of the company at a price of $24.99 per share. This transaction was documented in a recent SEC Filing. Following this sale, the insider now directly owns 34,159 shares of the company.
Artivion Inc, the company involved in this transaction, is engaged in the development and commercialization of medical devices for cardiovascular diseases and other medical needs.
Over the past year, the insider transaction history at Artivion Inc shows a total of 68 insider sells and no insider buys. The insider, Anthony Semedo, has sold a total of 9,709 shares over the past year and has not purchased any shares.
On the date of the insider's recent transaction, shares of Artivion Inc were trading at $24.99, giving the company a market cap of approximately $1.078 billion. According to the GF Value, which is an intrinsic value estimate used to gauge the fair value of stocks, Artivion Inc has a GF Value of $20.66. This places the stock's price-to-GF-Value ratio at 1.21, indicating that the stock is modestly overvalued.
The GF Value is determined by several factors including historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from analysts.
This sale by the insider at Artivion Inc provides investors with information on the actions of key executives and may prompt market watchers to closely monitor the company's stock and valuation metrics.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
